NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MicroPort CardioFlow Medtech Corporation

MicroPort CardioFlow Medtech Corporation

Shanghai, Shanghaicardioflowmedtech.com

Overview

MicroPort CardioFlow Medtech Corporation is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.

Year Founded

2009

Portfolio Companies

1

Investments

MicroPort CardioFlow Medtech Corporation investments
CompanyDateStageLead
4C Medical Technologies, Inc.Mar 2025Series DCo-investor
4C Medical Technologies, Inc.Mar 2022Series CLead
4C Medical Technologies, Inc.Sep 2018Series ALead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai, Shanghai
Year Founded2009

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.